# FDA UNTITLED_LETTER - Rx Unlimited Pharmacy - October 21, 2022

Source: https://www.globalkeysolutions.net/records/untitled_letter/rx-unlimited-pharmacy/24b3c562-b152-4a84-b0eb-e9b438dfd22d

> FDA UNTITLED_LETTER for Rx Unlimited Pharmacy on October 21, 2022. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: UNTITLED_LETTER
- Company Name: Rx Unlimited Pharmacy
- Inspection Date: 2022-10-21
- Product Type: Drugs
- Office Name: Division of Pharmaceutical Quality Operations I

## Related Documents

- [483 - 2022-10-21](https://www.globalkeysolutions.net/records/483/rx-unlimited-pharmacy/d8c69541-6046-4066-adde-360fd9c75ed3)

## Related Officers

- [Senior Lead Reviewer and Intercenter Consult Team Leader](https://www.globalkeysolutions.net/people/nayan-j-patel/0436f014-4b1b-4e54-8df0-576d51a354b2)
- [Program Division Director](https://www.globalkeysolutions.net/people/steven-e-porter/5448db0e-32f0-4e98-8a5f-9f0857373b06)
- [Payam Zarrabizadeh](https://www.globalkeysolutions.net/people/payam-zarrabizadeh/6bf5adae-e574-483d-8046-da94c2589d02)

Company: https://www.globalkeysolutions.net/companies/rx-unlimited-pharmacy/2dd716b6-69d5-4629-9fe8-43957344f923

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-i/6ded4818-ee3a-46a1-84c1-36de58502b02